Laser Photonics (LASE) Q1 2026 earnings summary

Executive summary

• Net sales for Q1 2026 were $915,553, down 60% year-over-year due to lower equipment deliveries and timing of customer orders.

• Achieved a major defense milestone with the Laser Shield Anti-Drone System selected by the U.S. Department of War and showcased at key industry events.

• Launched a new DefenseTech product line for military MRO and logistics, expanding into new markets.

• Entered medical device manufacturing with a significant order from Johnson & Johnson and secured additional orders across pharmaceutical, energy, and industrial sectors.

• Consolidated manufacturing operations to a single facility, targeting $1 million in annualized cost savings.

Financial highlights

• Net sales: $915,553 (Q1 2026), down from $2,290,282 (Q1 2025).

• Gross loss: $388,451 (Q1 2026) vs. gross profit of $900,491 (Q1 2025).

• Operating loss: $2,775,819 (Q1 2026), up 76.5% year-over-year.

• Net loss widened to $2,946,284 (Q1 2026), or $(0.16) per share attributable to common shareholders.

• Cash at period end: $1,627,600, up from $650,339 at year-end 2025.

Outlook and guidance

• Management expects Beamer Laser Marking Systems acquisition to drive revenue growth starting Q3 2026.

• Order book continued to build, with contract liabilities and deferred revenue rising to $4.2 million at quarter-end.

• Ongoing focus on capital raising, cost management, and increasing equipment sales to improve liquidity.

• Management prioritizes converting backlog into higher-margin revenue and sees defense as a durable growth vector.

• Continued uncertainty regarding ability to secure additional financing on acceptable terms.